NASDAQ:MTEX Mannatech (MTEX) Stock Price, News & Analysis $8.40 -0.02 (-0.24%) As of 02:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Mannatech Stock (NASDAQ:MTEX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Mannatech alerts:Sign Up Key Stats Today's Range$7.70▼$8.8050-Day Range$7.93▼$12.4052-Week Range$6.75▼$16.49Volume1,840 shsAverage Volume4,395 shsMarket Capitalization$15.97 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.Read More… Remove Ads Mannatech Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreMTEX MarketRank™: Mannatech scored higher than 6% of companies evaluated by MarketBeat, and ranked 905th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Mannatech. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Mannatech is -10.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Mannatech is -10.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMannatech has a P/B Ratio of 1.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Mannatech's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.51% of the float of Mannatech has been sold short.Short Interest Ratio / Days to CoverMannatech has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mannatech has recently increased by 2.19%, indicating that investor sentiment is decreasing. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldMannatech does not currently pay a dividend.Dividend GrowthMannatech does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Mannatech is 15.04%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Mannatech's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.51% of the float of Mannatech has been sold short.Short Interest Ratio / Days to CoverMannatech has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mannatech has recently increased by 2.19%, indicating that investor sentiment is decreasing. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Mannatech this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Mannatech insiders have not sold or bought any company stock.Percentage Held by Insiders41.50% of the stock of Mannatech is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 12.98% of the stock of Mannatech is held by institutions.Read more about Mannatech's insider trading history. Receive MTEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mannatech and its competitors with MarketBeat's FREE daily newsletter. Email Address MTEX Stock News HeadlinesMannatech (NASDAQ:MTEX) Coverage Initiated at StockNews.comApril 3 at 2:24 AM | americanbankingnews.comMannatech Reports Fourth Quarter 2024 Financial ResultsMarch 26, 2025 | businesswire.comThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.April 4, 2025 | Colonial Metals (Ad)Mannatech Stock Soars to 52-Week High, Hits $16 MarkJanuary 30, 2025 | msn.comMannatech names Robert Toth vice chairman of the boardNovember 27, 2024 | markets.businessinsider.comMannatech Announces Appointment of Robert A. Toth as Vice Chairman of the Board of DirectorsNovember 26, 2024 | businesswire.comMannatech Inc. Q3 Earnings SummaryNovember 13, 2024 | markets.businessinsider.comMannatech Reports Financial Results for Third Quarter 2024November 12, 2024 | businesswire.comSee More Headlines MTEX Stock Analysis - Frequently Asked Questions How have MTEX shares performed this year? Mannatech's stock was trading at $13.43 at the beginning of the year. Since then, MTEX shares have decreased by 37.5% and is now trading at $8.40. View the best growth stocks for 2025 here. How were Mannatech's earnings last quarter? Mannatech, Incorporated (NASDAQ:MTEX) issued its quarterly earnings results on Wednesday, March, 26th. The company reported $1.20 earnings per share for the quarter. The business had revenue of $29.01 million for the quarter. Mannatech had a negative net margin of 1.26% and a negative trailing twelve-month return on equity of 15.62%. How do I buy shares of Mannatech? Shares of MTEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Mannatech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Mannatech investors own include CrowdStrike (CRWD), Walt Disney (DIS), Herbalife (HLF), Roku (ROKU), Alibaba Group (BABA), Enphase Energy (ENPH) and Enterprise Products Partners (EPD). Company Calendar Last Earnings3/26/2025Today4/04/2025Next Earnings (Estimated)5/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:MTEX CIK1056358 Webwww.mannatech.com Phone(972) 471-7400Fax972-471-8117Employees250Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$1.33 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,240,000.00 Net Margins-1.26% Pretax Margin-0.82% Return on Equity-15.62% Return on Assets-3.76% Debt Debt-to-Equity Ratio0.44 Current Ratio1.25 Quick Ratio0.74 Sales & Book Value Annual Sales$117.87 million Price / Sales0.14 Cash FlowN/A Price / Cash FlowN/A Book Value$5.64 per share Price / Book1.49Miscellaneous Outstanding Shares1,901,000Free Float1,103,000Market Cap$15.97 million OptionableNot Optionable Beta0.98 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:MTEX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mannatech, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Mannatech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.